Akebia Therapeutics, Inc. (AKBA)
1.615
-0.04
(-2.71%)
USD |
NASDAQ |
Dec 15, 16:00
1.615
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Research and Development Expense (Annual): 31.99M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Ironwood Pharmaceuticals, Inc. | 109.41M |
| Pyxis Oncology, Inc. | 57.35M |
| Karyopharm Therapeutics, Inc. | 142.89M |
| Theravance Biopharma, Inc. | 36.04M |